INTEGRATED BIOPHARMA INC Cost-method Investments, Other than Temporary Impairment
INTEGRATED BIOPHARMA INC (INBP) reported Cost-method Investments, Other than Temporary Impairment of $358.00 thousand for the 12-month period ending 2018-06-30, per its 10-K filed 2019-08-29.
Discontinued › Expense Statement › Operating Expenses
us-gaap:CostmethodInvestmentsOtherThanTemporaryImpairment · last filed 2019-08-29
- INTEGRATED BIOPHARMA INC cost-method investments, other than temporary impairment for the quarter ending 2018-06-30 was $107.00K.
- INTEGRATED BIOPHARMA INC cost-method investments, other than temporary impairment for the quarter ending 2018-03-31 was $0.00.
- INTEGRATED BIOPHARMA INC cost-method investments, other than temporary impairment for the quarter ending 2017-12-31 was $168.00K.
- INTEGRATED BIOPHARMA INC cost-method investments, other than temporary impairment for the quarter ending 2017-09-30 was $83.00K.
- INTEGRATED BIOPHARMA INC cost-method investments, other than temporary impairment for fiscal 2018 was $358.00K, a 894.44% increase from fiscal 2017.
- INTEGRATED BIOPHARMA INC cost-method investments, other than temporary impairment for fiscal 2017 was $36.00K.
| Period end | Cost-method Investments, Other than Temporary Impairment 3 month | Cost-method Investments, Other than Temporary Impairment 6 month | Cost-method Investments, Other than Temporary Impairment 9 month | Cost-method Investments, Other than Temporary Impairment 12 month |
|---|---|---|---|---|
| 2018-06-30 | $107.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-29 | $107.00K derived: sum of 2 quarters · filed 2019-08-29 | $275.00K derived: sum of 3 quarters · filed 2019-08-29 | $358.00K 10-K · filed 2019-08-29 |
| 2018-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-05-15 | $168.00K derived: sum of 2 quarters · filed 2019-05-15 | $251.00K 10-Q · filed 2019-05-15 | $251.00K 10-Q · filed 2018-05-09 |
| 2017-12-31 | $168.00K 10-Q · filed 2019-02-13 | $251.00K 10-Q · filed 2019-02-13 | ||
| 2017-09-30 | $83.00K 10-Q · filed 2018-11-09 | |||
| 2017-06-30 | $36.00K 10-K · filed 2018-09-12 |